154 related articles for article (PubMed ID: 17054746)
1. Community response to intermittent preventive treatment delivered to infants (IPTi) through the EPI system in Manhiça, Mozambique.
Pool R; Munguambe K; Macete E; Aide P; Juma G; Alonso P; Menendez C
Trop Med Int Health; 2006 Nov; 11(11):1670-8. PubMed ID: 17054746
[TBL] [Abstract][Full Text] [Related]
2. The acceptability of intermittent preventive treatment of malaria in infants (IPTi) delivered through the expanded programme of immunization in southern Tanzania.
Pool R; Mushi A; Schellenberg JA; Mrisho M; Alonso P; Montgomery C; Tanner M; Mshinda H; Schellenberg D
Malar J; 2008 Oct; 7():213. PubMed ID: 18939971
[TBL] [Abstract][Full Text] [Related]
3. Acceptability of coupling intermittent preventive treatment in infants with the expanded programme on immunization in three francophone countries in Africa.
de Sousa A; Rabarijaona LP; Ndiaye JL; Sow D; Ndyiae M; Hassan J; Lambo N; Adovohekpe P; Guidetti F; Recht J; Affo A
Trop Med Int Health; 2012 Mar; 17(3):308-15. PubMed ID: 22128893
[TBL] [Abstract][Full Text] [Related]
4. Intermittent preventive treatment for malaria control administered at the time of routine vaccinations in Mozambican infants: a randomized, placebo-controlled trial.
Macete E; Aide P; Aponte JJ; Sanz S; Mandomando I; Espasa M; Sigauque B; Dobaño C; Mabunda S; DgeDge M; Alonso P; Menendez C
J Infect Dis; 2006 Aug; 194(3):276-85. PubMed ID: 16826474
[TBL] [Abstract][Full Text] [Related]
5. Community response to intermittent preventive treatment of malaria in infants (IPTi) delivered through the expanded programme of immunization in five African settings.
Gysels M; Pell C; Mathanga DP; Adongo P; Odhiambo F; Gosling R; Akweongo P; Mwangi R; Okello G; Mangesho P; Slutsker L; Kremsner PG; Grobusch MP; Hamel MJ; Newman RD; Pool R
Malar J; 2009 Aug; 8():191. PubMed ID: 19664250
[TBL] [Abstract][Full Text] [Related]
6. Intermittent preventive treatment for malaria and anaemia control in Tanzanian infants; the development and implementation of a public health strategy.
Manzi F; Schellenberg J; Hamis Y; Mushi AK; Shirima K; Mwita A; Simba A; Rusibamayila N; Kitambi M; Tanner M; Alonso P; Mshinda H; Schellenberg D
Trans R Soc Trop Med Hyg; 2009 Jan; 103(1):79-86. PubMed ID: 18823639
[TBL] [Abstract][Full Text] [Related]
7. Development of behaviour change communication strategy for a vaccination-linked malaria control tool in southern Tanzania.
Mushi AK; Schellenberg J; Mrisho M; Manzi F; Mbuya C; Mponda H; Mshinda H; Tanner M; Alonso P; Pool R; Schellenberg D
Malar J; 2008 Sep; 7():191. PubMed ID: 18823531
[TBL] [Abstract][Full Text] [Related]
8. Molecular markers of resistance to sulfadoxine-pyrimethamine during intermittent preventive treatment for malaria in Mozambican infants.
Mayor A; Serra-Casas E; Sanz S; Aponte JJ; Macete E; Mandomando I; Puyol L; Berzosa P; Dobaño C; Aide P; Sacarlal J; Benito A; Alonso P; Menéndez C
J Infect Dis; 2008 Jun; 197(12):1737-42. PubMed ID: 18419347
[TBL] [Abstract][Full Text] [Related]
9. Increase in EPI vaccines coverage after implementation of intermittent preventive treatment of malaria in infant with Sulfadoxine -pyrimethamine in the district of Kolokani, Mali: results from a cluster randomized control trial.
Dicko A; Toure SO; Traore M; Sagara I; Toure OB; Sissoko MS; Diallo AT; Rogier C; Salomon R; de Sousa A; Doumbo OK
BMC Public Health; 2011 Jul; 11():573. PubMed ID: 21767403
[TBL] [Abstract][Full Text] [Related]
10. Immune responses after single-dose sulphadoxine-pyrimethamine indicate underestimation of protective efficacy of intermittent preventive treatment in infants.
Schreiber N; Kobbe R; Adjei S; Adjei O; Klinkert MQ; May J
Trop Med Int Health; 2007 Oct; 12(10):1157-63. PubMed ID: 17956497
[TBL] [Abstract][Full Text] [Related]
11. Is the Expanded Programme on Immunisation the most appropriate delivery system for intermittent preventive treatment of malaria in West Africa?
Chandramohan D; Webster J; Smith L; Awine T; Owusu-Agyei S; Carneiro I
Trop Med Int Health; 2007 Jun; 12(6):743-50. PubMed ID: 17550471
[TBL] [Abstract][Full Text] [Related]
12. Intermittent preventive therapy for malaria: progress and future directions.
Grobusch MP; Egan A; Gosling RD; Newman RD
Curr Opin Infect Dis; 2007 Dec; 20(6):613-20. PubMed ID: 17975412
[TBL] [Abstract][Full Text] [Related]
13. Varying efficacy of intermittent preventive treatment for malaria in infants in two similar trials: public health implications.
Menendez C; Schellenberg D; Macete E; Aide P; Kahigwa E; Sanz S; Aponte JJ; Sacarlal J; Mshinda H; Tanner M; Alonso PL
Malar J; 2007 Sep; 6():132. PubMed ID: 17897454
[TBL] [Abstract][Full Text] [Related]
14. The IPTi Consortium: research for policy and action.
Schellenberg D; Cisse B; Menendez C
Trends Parasitol; 2006 Jul; 22(7):296-300. PubMed ID: 16713739
[TBL] [Abstract][Full Text] [Related]
15. Effect of a community-based delivery of intermittent preventive treatment of malaria in pregnancy on treatment seeking for malaria at health units in Uganda.
Mbonye AK; Schultz Hansen K; Bygbjerg IC; Magnussen P
Public Health; 2008 May; 122(5):516-25. PubMed ID: 18358506
[TBL] [Abstract][Full Text] [Related]
16. Community response to intermittent preventive treatment of malaria in infants (IPTi) in Papua New Guinea.
Pell C; Straus L; Phuanukoonnon S; Lupiwa S; Mueller I; Senn N; Siba P; Gysels M; Pool R
Malar J; 2010 Dec; 9():369. PubMed ID: 21176197
[
